Delivery Order SPE2DB25D3012-SPE2DB25FWXSW
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,036.57 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count units) under a firm fixed-price contract type. The award was made on August 26, 2025, with an ultimate completion date of August 27, 2025, and represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery order from its Conshohocken facility. This...
- The Defense Logistics Agency awarded a delivery order valued at $17,977.69 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (quantity: 30 count) under a firm fixed price contract. The award was made on August 20, 2025, with an ultimate completion date of August 21, 2025. This is a non-set-aside competitive award, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $13,026.20 to AmerisourceBergen Drug Corp on June 27, 2025, for the supply of Rexulti 3 mg tablets (30-count units). This firm fixed-price, non-competitive delivery order is scheduled for completion by June 30, 2025, with performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply needs. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $2,927.61 to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Rexulti 2 mg tablets (30-count). This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 15, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete in open federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Rexulti 2 mg tablets (30-count packages) with a ceiling value of $15,853.82. This competitively awarded, firm fixed-price delivery order is non-set-aside and carries an ultimate completion date of July 25, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $5,744.14 to AmerisourceBergen Drug Corp for the supply of Rexulti 0.5 mg tablets (30-count units) on June 17, 2025, with an ultimate completion date of June 18, 2025. This competitively awarded, firm fixed-price contract involves no set-aside provisions and represents a child order under AmerisourceBergen's larger pharmaceutical supply framework with the DLA. The product will be delivered to the company's headquarters in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,566.78 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count packages) under a firm fixed-price contract type. This delivery order, issued on August 22, 2025, with an ultimate completion date of August 25, 2025, represents a non-competitive procurement executed without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (30-count) on August 13, 2025, with a ceiling value of $1,002.23 and firm fixed pricing. This delivery order is non-set-aside and represents a competitive award to the pharmaceutical distributor, with an ultimate completion date of August 14, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a Delivery Order valued at $2,783.93 to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (30-count) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The order represents a single transaction under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $11,846.76 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count units) under a firm fixed price contract. The award, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical delivery order and functions as a...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FWXSWDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $14,851.46 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets in a 30-count package. This firm fixed price, competitively awarded contract was issued on June 2, 2025, with an ultimate completion date of June 3, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. As a non-set-aside procurement, this delivery order represents a routine pharmaceutical supply transaction under AmerisourceBergen's existing federal contracting relationship with the Defense Logistics Agency. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total value of $999,999,999.00 and extends through December 2026. This prime indefinite delivery vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, has established itself as a critical federal medical procurement vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through competitively awarded contracts demonstrating consistent capability to fulfill diverse federal medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.9k | 6/2/25 |